BTW Monday, Jan. 30, 1995 Share Tweet Read Later Send to Kindle Hydroxyurea, made by Bristol-Myers Squibb, is available for $100 a month, but insurers won't pay for it until the Food and Drug Administration specifically approves a sickle-cell use.
